Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions
{{output}}
The extent to which newer, incretin-based drugs for obesity improve disease outcomes via weight loss versus the direct effects of these drugs is the subject of intense interest. Although reductions in major adverse cardiovascular events appear to be predominan... ...
